MedTrace Logo

Maestro Handheld Cardiac Monitor Validation

NCT02977104 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2017-12-08

No results posted yet for this study

Summary

The purpose of this study is to demonstrate that the Maestro hand held heart monitor can accurately diagnose Atrial Fibrillation, atrial flutter or normal sinus rhythm in patients.

Conditions

  • Cardiac Arrhythmia

Interventions

OTHER

Maestro ECG

Telemetry is obtained through the Maestro handheld ECG device.

Sponsors & Collaborators

Principal Investigators

  • Rakesh Latchamsetty, MD · University of Michigan

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-07-01
Primary Completion
2017-12-05
Completion
2017-12-05

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02977104 on ClinicalTrials.gov